400 related articles for article (PubMed ID: 28368673)
1. Development and evaluation of orally disintegrating tablets comprising taste-masked mirtazapine granules.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Vural İ; Ünlü N
Pharm Dev Technol; 2018 Jun; 23(5):488-495. PubMed ID: 28368673
[TBL] [Abstract][Full Text] [Related]
2. Formulation studies for mirtazapine orally disintegrating tablets.
Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo investigation of taste-masking effectiveness of Eudragit E PO as drug particle coating agent in orally disintegrating tablets.
Drašković M; Medarević D; Aleksić I; Parojčić J
Drug Dev Ind Pharm; 2017 May; 43(5):723-731. PubMed ID: 27494420
[TBL] [Abstract][Full Text] [Related]
4. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
Chandrasekaran P; Kandasamy R
AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
[TBL] [Abstract][Full Text] [Related]
5. The effects of screw configuration and polymeric carriers on hot-melt extruded taste-masked formulations incorporated into orally disintegrating tablets.
Morott JT; Pimparade M; Park JB; Worley CP; Majumdar S; Lian Z; Pinto E; Bi Y; Durig T; Repka MA
J Pharm Sci; 2015 Jan; 104(1):124-34. PubMed ID: 25410968
[TBL] [Abstract][Full Text] [Related]
6. Development and optimization of taste-masked orally disintegrating tablets (ODTs) of clindamycin hydrochloride.
Cantor SL; Khan MA; Gupta A
Drug Dev Ind Pharm; 2015; 41(7):1156-64. PubMed ID: 25000481
[TBL] [Abstract][Full Text] [Related]
7. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
[TBL] [Abstract][Full Text] [Related]
8. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations.
Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W
Drug Dev Ind Pharm; 2015 Apr; 41(4):540-51. PubMed ID: 24495274
[TBL] [Abstract][Full Text] [Related]
9. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
Sheshala R; Khan N; Darwis Y
Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
[TBL] [Abstract][Full Text] [Related]
10. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
Tafere C; Yilma Z; Abrha S; Yehualaw A
PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
[TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets.
Douroumis DD; Gryczke A; Schminke S
AAPS PharmSciTech; 2011 Mar; 12(1):141-51. PubMed ID: 21181510
[TBL] [Abstract][Full Text] [Related]
12. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Chlorpheniramine Maleate microparticles in orally disintegrating film and orally disintegrating tablet for pediatrics.
Lou H; Liu M; Qu W; Hu Z; Brunson E; Johnson J; Almoazen H
Drug Dev Ind Pharm; 2014 Jul; 40(7):910-8. PubMed ID: 23621768
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of orally disintegrating tablets containing taste masked microparticles of acetaminophen.
Ikeuchi-Takahashi Y; Ito S; Itokawa A; Ota M; Onuki Y; Hidaka S; Onishi H
Pharmazie; 2020 Jan; 75(1):2-6. PubMed ID: 32033625
[TBL] [Abstract][Full Text] [Related]
15. Formulation and evaluation of bitter taste-masked orally disintegrating tablets of high memantine hydrochloride loaded granules coated with polymer via layering technique.
Kadota K; Terada H; Fujimoto A; Nogami S; Uchiyama H; Tozuka Y
Int J Pharm; 2021 Jul; 604():120725. PubMed ID: 34029663
[TBL] [Abstract][Full Text] [Related]
16. Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer's disease patients.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2015 Apr; 41(4):583-93. PubMed ID: 24495273
[TBL] [Abstract][Full Text] [Related]
17. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
[TBL] [Abstract][Full Text] [Related]
18. Formulation and in vitro evaluation of ketoprofen fast-dissolving tablets.
Comoglu T; Inal O; Yaacoub HB
Pharm Dev Technol; 2016 Dec; 21(8):901-908. PubMed ID: 25798913
[TBL] [Abstract][Full Text] [Related]
19. Investigation on the effect of polymer and starch on the tablet properties of lyophilized orally disintegrating tablet.
Liew KB; Peh KK
Arch Pharm Res; 2021 Aug; 44(8):1-10. PubMed ID: 25579848
[TBL] [Abstract][Full Text] [Related]
20. [Compliance in psychiatry: results of a survey of depressed patients using orally disintegrating tablet].
Danileviciūte V; Adomaitiene V; Sveikata A; Maciulaitis R; Kadusevicius E; Volbekas V
Medicina (Kaunas); 2006; 42(12):1006-12. PubMed ID: 17211109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]